GlassScriptPhysician profile
Steven L Halpern
NPI 1396791117
$625.01
in general payments reported to CMS, 2019-2025
11 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Pediatric Hematology-Oncology provider received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $14.99 · 2021: $11.16 · 2022: $14.05 · 2023: $73.72 · 2024: $29.40 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268 · Travel and Lodging: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.73 |
| Travel and Lodging | $196.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $434.62 | 2023-2025 | Aurora Ev-Icd Mri Surescan, Linq II |
| Genentech USA, INC. | $48.05 | 2019 | |
| Seagen INC. | $29.84 | 2019 | |
| Alnylam Pharmaceuticals INC. | $29.40 | 2024 | Amvuttra |
| Servier Pharmaceuticals LLC | $27.94 | 2019 | |
| Foundation Medicine, INC. | $14.99 | 2020 | |
| Pharmacyclics LLC, An Abbvie Company | $14.96 | 2019 | |
| Duchesnay USA Incorporated | $14.05 | 2022 | |
| Novartis Pharmaceuticals Corporation | $11.16 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Halpern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.